1. Home
  2. SENS vs TECX Comparison

SENS vs TECX Comparison

Compare SENS & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SENS
  • TECX
  • Stock Information
  • Founded
  • SENS 1996
  • TECX 2019
  • Country
  • SENS United States
  • TECX United States
  • Employees
  • SENS N/A
  • TECX N/A
  • Industry
  • SENS Industrial Machinery/Components
  • TECX
  • Sector
  • SENS Industrials
  • TECX
  • Exchange
  • SENS Nasdaq
  • TECX Nasdaq
  • Market Cap
  • SENS 360.5M
  • TECX 387.1M
  • IPO Year
  • SENS N/A
  • TECX 2018
  • Fundamental
  • Price
  • SENS $0.46
  • TECX $16.60
  • Analyst Decision
  • SENS Strong Buy
  • TECX Buy
  • Analyst Count
  • SENS 5
  • TECX 6
  • Target Price
  • SENS $1.63
  • TECX $79.17
  • AVG Volume (30 Days)
  • SENS 9.6M
  • TECX 480.8K
  • Earning Date
  • SENS 11-06-2025
  • TECX 11-06-2025
  • Dividend Yield
  • SENS N/A
  • TECX N/A
  • EPS Growth
  • SENS N/A
  • TECX N/A
  • EPS
  • SENS N/A
  • TECX N/A
  • Revenue
  • SENS $25,466,000.00
  • TECX N/A
  • Revenue This Year
  • SENS $62.96
  • TECX N/A
  • Revenue Next Year
  • SENS $72.62
  • TECX N/A
  • P/E Ratio
  • SENS N/A
  • TECX N/A
  • Revenue Growth
  • SENS 5.94
  • TECX N/A
  • 52 Week Low
  • SENS $0.25
  • TECX $13.70
  • 52 Week High
  • SENS $1.40
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • SENS 48.64
  • TECX 49.02
  • Support Level
  • SENS $0.45
  • TECX $14.62
  • Resistance Level
  • SENS $0.58
  • TECX $15.47
  • Average True Range (ATR)
  • SENS 0.03
  • TECX 0.96
  • MACD
  • SENS 0.00
  • TECX 0.32
  • Stochastic Oscillator
  • SENS 27.48
  • TECX 91.97

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: